Dorstenia psilurus
Dorstenia psilurus · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Dorstenia psilurus is a botanical species that has garnered significant scientific interest due to its diverse therapeutic potential. Research focuses primarily on the plant's root, utilizing various preparations such as methanol and methanol/methylene chloride extracts. These studies have highlighted the plant's notable antibacterial, antihypertensive, and cytotoxic activities. Specifically, the medicinal extracts show promise in managing health conditions like high blood pressure, hypertension, and elevated cholesterol levels. Furthermore, investigations into these root extracts suggest their potential role in regulating creatinine levels within the body.
- Synonyms
- Dorstenia Psilurus Var. Compacta · Dorstenia Stolzii · 13 more
- Common names
- Not available
- Family
- Moraceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Common Names
Dorstenia psilurus is a distinctive botanical species known for its unique structural characteristics. In various local contexts, this plant is widely recognized by its common name, kongonlonkio. This name serves as a vital linguistic link between the plant's scientific identity and its cultural significance. Understanding these regional labels helps researchers and enthusiasts better navigate its natural habitat. Ultimately, bridging the gap between formal taxonomy and common nomenclature enriches our appreciation for the species.
Sources: Catalogue of Life (COL)
Synonyms
Dorstenia psilurus is a species characterized by a complex botanical history involving several taxonomic synonyms. Throughout various studies, this plant has been identified under multiple names, including Dorstenia bicornis and Dorstenia gilletii. It has also been referred to in scientific literature as Dorstenia klaineana and Dorstenia klainei. Furthermore, the designation Dorstenia lukafuensis has been applied to the same organism in different contexts. Understanding these overlapping names is essential for accurate classification and study within the genus.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Dorstenia psilurus is a distinct biological entity that belongs to the vast kingdom Plantae. Within this expansive kingdom, it is specifically classified under the class Equisetopsida. This plant further belongs to the order Rosales, reflecting its evolutionary lineage. It is a member of the Moraceae family, a group known for its diverse botanical characteristics. Finally, it is identified by its specific genus, Dorstenia, which defines its unique botanical identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Rosales |
| Family | Moraceae |
| Genus | Dorstenia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Dorstenia psilurus is a resilient species characterized by its widespread presence across various regions of the African continent. Its geographical range extends through East Tropical Africa, where it can be found natively in both Tanzania and Uganda. Moving toward the north, the plant also inhabits parts of Northeast Tropical Africa, specifically within the Sudan and South Sudan regions. Furthermore, its distribution reaches into South Tropical Africa, spanning across territories such as Malawi and Angola. This diverse range highlights the plant's ability to thrive in multiple distinct ecological zones throughout Africa.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Dorstenia psilurus is a self-supporting herb that grows naturally within its habitat. This species is characterized by its upright growth form, which allows it to remain stable without external support. Reaching a maximum height of approximately 3.66 meters, it stands as a prominent feature of its local environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Dorstenia psilurus, a spice widely used in Cameroon, has demonstrated significant therapeutic potential across several biological activities. Research indicates that the plant possesses notable antibacterial properties, particularly when used to enhance the efficacy of antibiotics against multi-drug resistant bacteria. Furthermore, studies on hypertensive rat models suggest that its extracts may help prevent and reverse high blood pressure induced by fructose-rich diets. The plant also exhibits potent cytotoxic activity, specifically showing the ability to induce apoptosis in human leukemia and prostate cancer cells. Collectively, these findings highlight the multifaceted medicinal value of Dorstenia psilurus in combating infection, hypertension, and cancer.
Compounds
Dorstenia psilurus serves as a significant source of bioactive compounds, most notably the isoprenylated flavonoid known as artelasticin. Research indicates that artelasticin, along with its structural isomer, plays a critical role in activating the AMP-activated protein kinase (AMPK) pathway. By stimulating glucose uptake and inhibiting glucose production, these compounds demonstrate a powerful potential for regulating glycemia. Furthermore, studies in insulin-resistant mice have shown that artelasticin effectively lowers blood glucose levels, highlighting its metabolic importance. These findings suggest that the chemical constituents found within Dorstenia psilurus could become essential building blocks for developing new treatments for type 2 diabetes.
Conditions
Dorstenia psilurus demonstrates significant therapeutic potential by inhibiting alpha-glucosidase through its unique triprenylated flavonoids. The plant extract effectively manages cholesterol levels, contributing to improved metabolic profiles in studied subjects. It also plays a role in addressing creatinine levels and mitigating the effects of fructose-induced hypertension. Furthermore, the plant's bioactive compounds assist in regulating glucose production to help lower glycemia. These combined properties suggest that Dorstenia psilurus could be a valuable resource for treating metabolic disorders.
Preparations
Dorstenia psilurus is prepared as root extracts to purify isoprenylated flavonoids that activate AMPK and regulate glucose levels. This medicinal plant is also processed as a methanol extract to investigate its significant cytotoxic and apoptotic potential against leukemia and prostate cancer cells. Research further utilizes Dorstenia psilurus as a methanol extract to evaluate its antibacterial properties and its ability to potentiate certain antibiotics. Additionally, the plant is prepared as a methanol/methylene chloride extract to demonstrate antihypertensive effects in rat models. Various studies confirm that Dorstenia psilurus is prepared as an extract to explore its diverse therapeutic applications in treating metabolic and infectious diseases.
Parts used
Dorstenia psilurus contains unique bioactive compounds that are primarily sourced from its root system. Researchers have successfully isolated several triprenylated flavonoids, such as dorsilurins F-K, from these plant roots. These specific chemical structures have demonstrated moderate to low inhibitory activity against the enzyme alpha-glucosidase. Furthermore, isoprenylated flavones extracted from the plant have been shown to activate AMPK and stimulate glucose uptake in various cell models. Because of these potent metabolic effects, the chemical constituents of the Dorstenia psilurus root may serve as a foundation for developing new treatments for type 2 diabetes.